APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fluphenazine Decanoate

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Fluphenazine Decanoate Market Analysis and Forecast 2026-2032

19 December 2025190 pages

Choose your research edition.

Industry ResearchFluphenazine Decanoate Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Fluphenazine Decanoate Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Fluphenazine Decanoate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fluphenazine Decanoate Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Fluphenazine Decanoate Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Fluphenazine Decanoate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Fluphenazine Decanoate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Fluphenazine Decanoate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Fluphenazine Decanoate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Fluphenazine Decanoate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Fluphenazine Decanoate include Atlantic Laboratories Corporation,Ltd., AUROBINDO PHARMA LTD, FRESENIUS KABI USA, MYLAN LABS LTD, PAR STERILE PRODUCTS, WEST-WARD PHARMS INT, Shanghai Harvest Pharmaceutical, Shanghai Zhongxi Sunve Pharmaceutical and Southwest Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Fluphenazine Decanoate, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Fluphenazine Decanoate, also provides the revenue of main regions and countries. Of the upcoming market potential for Fluphenazine Decanoate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Fluphenazine Decanoate revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fluphenazine Decanoate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Fluphenazine Decanoate revenue, projected growth trends, production technology, application and end-user industry.

Fluphenazine Decanoate Segment by Company

Atlantic Laboratories Corporation,Ltd.

AUROBINDO PHARMA LTD

FRESENIUS KABI USA

MYLAN LABS LTD

PAR STERILE PRODUCTS

WEST-WARD PHARMS INT

Shanghai Harvest Pharmaceutical

Shanghai Zhongxi Sunve Pharmaceutical

Southwest Pharmaceutical

Fluphenazine Decanoate Segment by Type

Acute Schizophrenia

Chronic Schizophrenia

Others

Fluphenazine Decanoate Segment by Application

Children

Adult

Fluphenazine Decanoate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fluphenazine Decanoate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fluphenazine Decanoate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fluphenazine Decanoate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Fluphenazine Decanoate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Fluphenazine Decanoate company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fluphenazine Decanoate revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Fluphenazine Decanoate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Acute Schizophrenia Major Player Table 3. Chronic Schizophrenia Major Player Table 4. Others Major Player Table 5. Global Fluphenazine Decanoate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Children Major Player Table 7. Adult Major Player Table 8. Fluphenazine Decanoate Industry Trends Table 9. Fluphenazine Decanoate Industry Drivers Table 10. Fluphenazine Decanoate Industry Opportunities and Challenges Table 11. Fluphenazine Decanoate Industry Restraints Table 12. Global Fluphenazine Decanoate Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Fluphenazine Decanoate Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Fluphenazine Decanoate Market Share by Region (2021-2026) Table 15. Global Fluphenazine Decanoate Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Fluphenazine Decanoate Market Share by Region (2027-2032) Table 17. Global Fluphenazine Decanoate Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Fluphenazine Decanoate Revenue Market Share by Players (2021-2026) Table 19. Global Fluphenazine Decanoate Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Fluphenazine Decanoate Key Players Headquarters & Area Served Table 21. Global Fluphenazine Decanoate Players, Product Type & Application Table 22. Global Fluphenazine Decanoate Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Fluphenazine Decanoate by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Fluphenazine Decanoate Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Fluphenazine Decanoate Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Fluphenazine Decanoate Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Fluphenazine Decanoate Revenue Market Share by Type (2021-2026) Table 29. Global Fluphenazine Decanoate Revenue Market Share by Type (2027-2032) Table 30. Global Fluphenazine Decanoate Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Fluphenazine Decanoate Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Fluphenazine Decanoate Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Fluphenazine Decanoate Revenue Market Share by Application (2021-2026) Table 34. Global Fluphenazine Decanoate Revenue Market Share by Application (2027-2032) Table 35. Atlantic Laboratories Corporation,Ltd. Company Information Table 36. Atlantic Laboratories Corporation,Ltd. Business Overview Table 37. Atlantic Laboratories Corporation,Ltd. Fluphenazine Decanoate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Atlantic Laboratories Corporation,Ltd. Fluphenazine Decanoate Product Portfolio Table 39. Atlantic Laboratories Corporation,Ltd. Recent Development Table 40. AUROBINDO PHARMA LTD Company Information Table 41. AUROBINDO PHARMA LTD Business Overview Table 42. AUROBINDO PHARMA LTD Fluphenazine Decanoate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. AUROBINDO PHARMA LTD Fluphenazine Decanoate Product Portfolio Table 44. AUROBINDO PHARMA LTD Recent Development Table 45. FRESENIUS KABI USA Company Information Table 46. FRESENIUS KABI USA Business Overview Table 47. FRESENIUS KABI USA Fluphenazine Decanoate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. FRESENIUS KABI USA Fluphenazine Decanoate Product Portfolio Table 49. FRESENIUS KABI USA Recent Development Table 50. MYLAN LABS LTD Company Information Table 51. MYLAN LABS LTD Business Overview Table 52. MYLAN LABS LTD Fluphenazine Decanoate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. MYLAN LABS LTD Fluphenazine Decanoate Product Portfolio Table 54. MYLAN LABS LTD Recent Development Table 55. PAR STERILE PRODUCTS Company Information Table 56. PAR STERILE PRODUCTS Business Overview Table 57. PAR STERILE PRODUCTS Fluphenazine Decanoate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. PAR STERILE PRODUCTS Fluphenazine Decanoate Product Portfolio Table 59. PAR STERILE PRODUCTS Recent Development Table 60. WEST-WARD PHARMS INT Company Information Table 61. WEST-WARD PHARMS INT Business Overview Table 62. WEST-WARD PHARMS INT Fluphenazine Decanoate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. WEST-WARD PHARMS INT Fluphenazine Decanoate Product Portfolio Table 64. WEST-WARD PHARMS INT Recent Development Table 65. Shanghai Harvest Pharmaceutical Company Information Table 66. Shanghai Harvest Pharmaceutical Business Overview Table 67. Shanghai Harvest Pharmaceutical Fluphenazine Decanoate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Shanghai Harvest Pharmaceutical Fluphenazine Decanoate Product Portfolio Table 69. Shanghai Harvest Pharmaceutical Recent Development Table 70. Shanghai Zhongxi Sunve Pharmaceutical Company Information Table 71. Shanghai Zhongxi Sunve Pharmaceutical Business Overview Table 72. Shanghai Zhongxi Sunve Pharmaceutical Fluphenazine Decanoate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Shanghai Zhongxi Sunve Pharmaceutical Fluphenazine Decanoate Product Portfolio Table 74. Shanghai Zhongxi Sunve Pharmaceutical Recent Development Table 75. Southwest Pharmaceutical Company Information Table 76. Southwest Pharmaceutical Business Overview Table 77. Southwest Pharmaceutical Fluphenazine Decanoate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Southwest Pharmaceutical Fluphenazine Decanoate Product Portfolio Table 79. Southwest Pharmaceutical Recent Development Table 80. North America Fluphenazine Decanoate Revenue by Type (2021-2026) & (US$ Million) Table 81. North America Fluphenazine Decanoate Revenue by Type (2027-2032) & (US$ Million) Table 82. North America Fluphenazine Decanoate Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Fluphenazine Decanoate Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Fluphenazine Decanoate Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Fluphenazine Decanoate Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Fluphenazine Decanoate Revenue by Country (US$ Million) & (2027-2032) Table 87. Europe Fluphenazine Decanoate Revenue by Type (2021-2026) & (US$ Million) Table 88. Europe Fluphenazine Decanoate Revenue by Type (2027-2032) & (US$ Million) Table 89. Europe Fluphenazine Decanoate Revenue by Application (2021-2026) & (US$ Million) Table 90. Europe Fluphenazine Decanoate Revenue by Application (2027-2032) & (US$ Million) Table 91. Europe Fluphenazine Decanoate Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Fluphenazine Decanoate Revenue by Country (2021-2026) & (US$ Million) Table 93. Europe Fluphenazine Decanoate Revenue by Country (US$ Million) & (2027-2032) Table 94. China Fluphenazine Decanoate Revenue by Type (2021-2026) & (US$ Million) Table 95. China Fluphenazine Decanoate Revenue by Type (2027-2032) & (US$ Million) Table 96. China Fluphenazine Decanoate Revenue by Application (2021-2026) & (US$ Million) Table 97. China Fluphenazine Decanoate Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Fluphenazine Decanoate Revenue by Type (2021-2026) & (US$ Million) Table 99. Asia Fluphenazine Decanoate Revenue by Type (2027-2032) & (US$ Million) Table 100. Asia Fluphenazine Decanoate Revenue by Application (2021-2026) & (US$ Million) Table 101. Asia Fluphenazine Decanoate Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Fluphenazine Decanoate Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Fluphenazine Decanoate Revenue by Region (US$ Million) & (2021-2026) Table 104. Asia Fluphenazine Decanoate Revenue by Region (US$ Million) & (2027-2032) Table 105. SAMEA Fluphenazine Decanoate Revenue by Type (2021-2026) & (US$ Million) Table 106. SAMEA Fluphenazine Decanoate Revenue by Type (2027-2032) & (US$ Million) Table 107. SAMEA Fluphenazine Decanoate Revenue by Application (2021-2026) & (US$ Million) Table 108. SAMEA Fluphenazine Decanoate Revenue by Application (2027-2032) & (US$ Million) Table 109. SAMEA Fluphenazine Decanoate Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. SAMEA Fluphenazine Decanoate Revenue by Country (2021-2026) & (US$ Million) Table 111. SAMEA Fluphenazine Decanoate Revenue by Country (US$ Million) & (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Fluphenazine Decanoate Image Figure 2. Global Fluphenazine Decanoate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fluphenazine Decanoate Market Size Share 2021 VS 2025 VS 2032 Figure 4. Acute Schizophrenia Image Figure 5. Chronic Schizophrenia Image Figure 6. Others Image Figure 7. Global Fluphenazine Decanoate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Fluphenazine Decanoate Market Size Share 2021 VS 2025 VS 2032 Figure 9. Children Image Figure 10. Adult Image Figure 11. Global Fluphenazine Decanoate Market Size (US$ Million) & (2021-2032) Figure 12. Global Fluphenazine Decanoate Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Fluphenazine Decanoate Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Fluphenazine Decanoate Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Fluphenazine Decanoate Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Fluphenazine Decanoate Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Fluphenazine Decanoate Revenue Market Share by Type (2021-2032) Figure 19. Global Fluphenazine Decanoate Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Fluphenazine Decanoate Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Fluphenazine Decanoate Revenue Market Share by Application (2021-2032) Figure 22. North America Fluphenazine Decanoate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Fluphenazine Decanoate Revenue Share by Type (2021-2032) Figure 24. North America Fluphenazine Decanoate Revenue Share by Application (2021-2032) Figure 25. North America Fluphenazine Decanoate Revenue Share by Country (2021-2032) Figure 26. United States Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Fluphenazine Decanoate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Fluphenazine Decanoate Revenue Share by Type (2021-2032) Figure 31. Europe Fluphenazine Decanoate Revenue Share by Application (2021-2032) Figure 32. Europe Fluphenazine Decanoate Revenue Share by Country (2021-2032) Figure 33. Germany Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Fluphenazine Decanoate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Fluphenazine Decanoate Revenue Share by Type (2021-2032) Figure 43. China Fluphenazine Decanoate Revenue Share by Application (2021-2032) Figure 44. Asia Fluphenazine Decanoate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Fluphenazine Decanoate Revenue Share by Type (2021-2032) Figure 46. Asia Fluphenazine Decanoate Revenue Share by Application (2021-2032) Figure 47. Asia Fluphenazine Decanoate Revenue Share by Region (2021-2032) Figure 48. Japan Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Fluphenazine Decanoate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Fluphenazine Decanoate Revenue Share by Type (2021-2032) Figure 56. SAMEA Fluphenazine Decanoate Revenue Share by Application (2021-2032) Figure 57. SAMEA Fluphenazine Decanoate Revenue Share by Country (2021-2032) Figure 58. Brazil Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Fluphenazine Decanoate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Acute Schizophrenia
  • Chronic Schizophrenia
  • Others
Applications
  • Children
  • Adult
Companies covered
  • Atlantic Laboratories Corporation,Ltd.
  • AUROBINDO PHARMA LTD
  • FRESENIUS KABI USA
  • MYLAN LABS LTD
  • PAR STERILE PRODUCTS
  • WEST-WARD PHARMS INT
  • Shanghai Harvest Pharmaceutical
  • Shanghai Zhongxi Sunve Pharmaceutical
  • Southwest Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Fluphenazine Decanoate Market by Type
  3. 1.2.1 Global Fluphenazine Decanoate Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Acute Schizophrenia
  5. 1.2.3 Chronic Schizophrenia
  6. 1.2.4 Others
  7. 1.3 Fluphenazine Decanoate Market by Application
  8. 1.3.1 Global Fluphenazine Decanoate Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Children
  10. 1.3.3 Adult
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Fluphenazine Decanoate Market Dynamics
  1. 2.1 Fluphenazine Decanoate Industry Trends
  2. 2.2 Fluphenazine Decanoate Industry Drivers
  3. 2.3 Fluphenazine Decanoate Industry Opportunities and Challenges
  4. 2.4 Fluphenazine Decanoate Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Fluphenazine Decanoate Market Perspective (2021-2032)
  2. 3.2 Global Fluphenazine Decanoate Growth Trends by Region
  3. 3.2.1 Global Fluphenazine Decanoate Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Fluphenazine Decanoate Market Size by Region (2021-2026)
  5. 3.2.3 Global Fluphenazine Decanoate Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Fluphenazine Decanoate Revenue by Players
  2. 4.1.1 Global Fluphenazine Decanoate Revenue by Players (2021-2026)
  3. 4.1.2 Global Fluphenazine Decanoate Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Fluphenazine Decanoate Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Fluphenazine Decanoate Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Fluphenazine Decanoate Key Players Headquarters & Area Served
  7. 4.4 Global Fluphenazine Decanoate Players, Product Type & Application
  8. 4.5 Global Fluphenazine Decanoate Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Fluphenazine Decanoate Market CR5 and HHI
  11. 4.6.3 2025 Fluphenazine Decanoate Tier 1, Tier 2, and Tier 3
5 Fluphenazine Decanoate Market Size by Type
  1. 5.1 Global Fluphenazine Decanoate Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Fluphenazine Decanoate Revenue by Type (2021-2032)
  3. 5.3 Global Fluphenazine Decanoate Revenue Market Share by Type (2021-2032)
6 Fluphenazine Decanoate Market Size by Application
  1. 6.1 Global Fluphenazine Decanoate Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Fluphenazine Decanoate Revenue by Application (2021-2032)
  3. 6.3 Global Fluphenazine Decanoate Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Atlantic Laboratories Corporation,Ltd.
  2. 7.1.1 Atlantic Laboratories Corporation,Ltd. Company Information
  3. 7.1.2 Atlantic Laboratories Corporation,Ltd. Business Overview
  4. 7.1.3 Atlantic Laboratories Corporation,Ltd. Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Atlantic Laboratories Corporation,Ltd. Fluphenazine Decanoate Product Portfolio
  6. 7.1.5 Atlantic Laboratories Corporation,Ltd. Recent Developments
  7. 7.2 AUROBINDO PHARMA LTD
  8. 7.2.1 AUROBINDO PHARMA LTD Company Information
  9. 7.2.2 AUROBINDO PHARMA LTD Business Overview
  10. 7.2.3 AUROBINDO PHARMA LTD Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AUROBINDO PHARMA LTD Fluphenazine Decanoate Product Portfolio
  12. 7.2.5 AUROBINDO PHARMA LTD Recent Developments
  13. 7.3 FRESENIUS KABI USA
  14. 7.3.1 FRESENIUS KABI USA Company Information
  15. 7.3.2 FRESENIUS KABI USA Business Overview
  16. 7.3.3 FRESENIUS KABI USA Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  17. 7.3.4 FRESENIUS KABI USA Fluphenazine Decanoate Product Portfolio
  18. 7.3.5 FRESENIUS KABI USA Recent Developments
  19. 7.4 MYLAN LABS LTD
  20. 7.4.1 MYLAN LABS LTD Company Information
  21. 7.4.2 MYLAN LABS LTD Business Overview
  22. 7.4.3 MYLAN LABS LTD Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  23. 7.4.4 MYLAN LABS LTD Fluphenazine Decanoate Product Portfolio
  24. 7.4.5 MYLAN LABS LTD Recent Developments
  25. 7.5 PAR STERILE PRODUCTS
  26. 7.5.1 PAR STERILE PRODUCTS Company Information
  27. 7.5.2 PAR STERILE PRODUCTS Business Overview
  28. 7.5.3 PAR STERILE PRODUCTS Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  29. 7.5.4 PAR STERILE PRODUCTS Fluphenazine Decanoate Product Portfolio
  30. 7.5.5 PAR STERILE PRODUCTS Recent Developments
  31. 7.6 WEST-WARD PHARMS INT
  32. 7.6.1 WEST-WARD PHARMS INT Company Information
  33. 7.6.2 WEST-WARD PHARMS INT Business Overview
  34. 7.6.3 WEST-WARD PHARMS INT Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  35. 7.6.4 WEST-WARD PHARMS INT Fluphenazine Decanoate Product Portfolio
  36. 7.6.5 WEST-WARD PHARMS INT Recent Developments
  37. 7.7 Shanghai Harvest Pharmaceutical
  38. 7.7.1 Shanghai Harvest Pharmaceutical Company Information
  39. 7.7.2 Shanghai Harvest Pharmaceutical Business Overview
  40. 7.7.3 Shanghai Harvest Pharmaceutical Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Shanghai Harvest Pharmaceutical Fluphenazine Decanoate Product Portfolio
  42. 7.7.5 Shanghai Harvest Pharmaceutical Recent Developments
  43. 7.8 Shanghai Zhongxi Sunve Pharmaceutical
  44. 7.8.1 Shanghai Zhongxi Sunve Pharmaceutical Company Information
  45. 7.8.2 Shanghai Zhongxi Sunve Pharmaceutical Business Overview
  46. 7.8.3 Shanghai Zhongxi Sunve Pharmaceutical Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Shanghai Zhongxi Sunve Pharmaceutical Fluphenazine Decanoate Product Portfolio
  48. 7.8.5 Shanghai Zhongxi Sunve Pharmaceutical Recent Developments
  49. 7.9 Southwest Pharmaceutical
  50. 7.9.1 Southwest Pharmaceutical Company Information
  51. 7.9.2 Southwest Pharmaceutical Business Overview
  52. 7.9.3 Southwest Pharmaceutical Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Southwest Pharmaceutical Fluphenazine Decanoate Product Portfolio
  54. 7.9.5 Southwest Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Fluphenazine Decanoate Revenue (2021-2032)
  2. 8.2 North America Fluphenazine Decanoate Revenue by Type (2021-2032)
  3. 8.2.1 North America Fluphenazine Decanoate Revenue by Type (2021-2026)
  4. 8.2.2 North America Fluphenazine Decanoate Revenue by Type (2027-2032)
  5. 8.3 North America Fluphenazine Decanoate Revenue Share by Type (2021-2032)
  6. 8.4 North America Fluphenazine Decanoate Revenue by Application (2021-2032)
  7. 8.4.1 North America Fluphenazine Decanoate Revenue by Application (2021-2026)
  8. 8.4.2 North America Fluphenazine Decanoate Revenue by Application (2027-2032)
  9. 8.5 North America Fluphenazine Decanoate Revenue Share by Application (2021-2032)
  10. 8.6 North America Fluphenazine Decanoate Revenue by Country
  11. 8.6.1 North America Fluphenazine Decanoate Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Fluphenazine Decanoate Revenue by Country (2021-2026)
  13. 8.6.3 North America Fluphenazine Decanoate Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Fluphenazine Decanoate Revenue (2021-2032)
  2. 9.2 Europe Fluphenazine Decanoate Revenue by Type (2021-2032)
  3. 9.2.1 Europe Fluphenazine Decanoate Revenue by Type (2021-2026)
  4. 9.2.2 Europe Fluphenazine Decanoate Revenue by Type (2027-2032)
  5. 9.3 Europe Fluphenazine Decanoate Revenue Share by Type (2021-2032)
  6. 9.4 Europe Fluphenazine Decanoate Revenue by Application (2021-2032)
  7. 9.4.1 Europe Fluphenazine Decanoate Revenue by Application (2021-2026)
  8. 9.4.2 Europe Fluphenazine Decanoate Revenue by Application (2027-2032)
  9. 9.5 Europe Fluphenazine Decanoate Revenue Share by Application (2021-2032)
  10. 9.6 Europe Fluphenazine Decanoate Revenue by Country
  11. 9.6.1 Europe Fluphenazine Decanoate Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Fluphenazine Decanoate Revenue by Country (2021-2026)
  13. 9.6.3 Europe Fluphenazine Decanoate Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Fluphenazine Decanoate Revenue (2021-2032)
  2. 10.2 China Fluphenazine Decanoate Revenue by Type (2021-2032)
  3. 10.2.1 China Fluphenazine Decanoate Revenue by Type (2021-2026)
  4. 10.2.2 China Fluphenazine Decanoate Revenue by Type (2027-2032)
  5. 10.3 China Fluphenazine Decanoate Revenue Share by Type (2021-2032)
  6. 10.4 China Fluphenazine Decanoate Revenue by Application (2021-2032)
  7. 10.4.1 China Fluphenazine Decanoate Revenue by Application (2021-2026)
  8. 10.4.2 China Fluphenazine Decanoate Revenue by Application (2027-2032)
  9. 10.5 China Fluphenazine Decanoate Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Fluphenazine Decanoate Revenue (2021-2032)
  2. 11.2 Asia Fluphenazine Decanoate Revenue by Type (2021-2032)
  3. 11.2.1 Asia Fluphenazine Decanoate Revenue by Type (2021-2026)
  4. 11.2.2 Asia Fluphenazine Decanoate Revenue by Type (2027-2032)
  5. 11.3 Asia Fluphenazine Decanoate Revenue Share by Type (2021-2032)
  6. 11.4 Asia Fluphenazine Decanoate Revenue by Application (2021-2032)
  7. 11.4.1 Asia Fluphenazine Decanoate Revenue by Application (2021-2026)
  8. 11.4.2 Asia Fluphenazine Decanoate Revenue by Application (2027-2032)
  9. 11.5 Asia Fluphenazine Decanoate Revenue Share by Application (2021-2032)
  10. 11.6 Asia Fluphenazine Decanoate Revenue by Country
  11. 11.6.1 Asia Fluphenazine Decanoate Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Fluphenazine Decanoate Revenue by Country (2021-2026)
  13. 11.6.3 Asia Fluphenazine Decanoate Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Fluphenazine Decanoate Revenue (2021-2032)
  2. 12.2 SAMEA Fluphenazine Decanoate Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Fluphenazine Decanoate Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Fluphenazine Decanoate Revenue by Type (2027-2032)
  5. 12.3 SAMEA Fluphenazine Decanoate Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Fluphenazine Decanoate Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Fluphenazine Decanoate Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Fluphenazine Decanoate Revenue by Application (2027-2032)
  9. 12.5 SAMEA Fluphenazine Decanoate Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Fluphenazine Decanoate Revenue by Country
  11. 12.6.1 SAMEA Fluphenazine Decanoate Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Fluphenazine Decanoate Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Fluphenazine Decanoate Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst